These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 149598)

  • 1. [Formation and persistence of antibodies against envelope antigens of influenza virus after vaccination by formolized monovaccine (author's transl)].
    Stumpa A; Bruj J; Tůmová B; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1978 Feb; 27(1):29-37. PubMed ID: 149598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formation and persistence of antibodies against antigens of influenza virus envelope after natural infection (author's transl)].
    Stumpa A; Kulková H; Tůmová B
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):69-78. PubMed ID: 149605
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influenza vaccination in dialysis patients].
    Haldimann B; Descoeudres C
    Schweiz Med Wochenschr; 1978 Jan; 108(2):52-5. PubMed ID: 622534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines.
    Potter CW; Jennings R; Clark A
    Dev Biol Stand; 1977 Jun 1-3; 39():323-8. PubMed ID: 604115
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
    Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
    Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza and the swine influenza virus.
    Hattwick MA; O'Brien RJ; Hoke CH; Dowdle WR
    Bull Pan Am Health Organ; 1976; 10(4):283-92. PubMed ID: 799946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunogenicity of recombinant influenza virus vaccines (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I; Takahashi M; Miki Y
    Uirusu; 1979 Dec; 29(2):127-39. PubMed ID: 550564
    [No Abstract]   [Full Text] [Related]  

  • 15. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection.
    Wood JM; Kawaoka Y; Newberry LA; Bordwell E; Webster RG
    Avian Dis; 1985; 29(3):867-72. PubMed ID: 4074253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Kasel JA; Laver WG
    Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
    Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
    Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looming flu pandemic has experts crying fowl.
    Clayton J
    Nat Med; 2003 Apr; 9(4):375. PubMed ID: 12669040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.